[Guidelines of the DGVS. Pouchitis. German Society of Digestive and Metabolic Diseases].
Zeitz
M
M
D000359:Aftercare; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology; D008795:Metronidazole / Q000008:administration & dosage / Q000009:adverse effects; D019449:Pouchitis / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D013256:Steroids
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013256:Steroids; D008795:Metronidazole
Leitlinien der DGVS. Pouchitis.